NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Activity
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

66 hedge funds and large institutions have $15.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
14
Reduced
20
Closed
14
Calls
$40K
Puts
$397K
Net Calls
-$357K
Net Calls Change
-$2.04M

Top Buyers

1
TI
Turner Investments
Pennsylvania
$1.34M
2
AllianceBernstein
AllianceBernstein
Tennessee
$1.01M
3
Goldman Sachs
Goldman Sachs
New York
$146K
4
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$118K
5
HighTower Advisors
HighTower Advisors
Illinois
$100K

Top Sellers

1
BFA
BlackRock Fund Advisors
California
$176K
2
State Street
State Street
Massachusetts
$28K
3
SFM
Sphera Funds Management
Israel
$0
4
BIT
BlackRock Institutional Trust
California
$48K
5
DBG
De Burlo Group
Massachusetts
$32K
Name Holding Trade Value Shares
Change 		Shares
Change %
NFA
76
Nationwide Fund Advisors
Ohio
– -$39K -38 Closed
BA
77
BlackRock Advisors
Delaware
– -$25K -24 Closed
MFS
78
MSI Financial Services
Massachusetts
– -$13K -13 Closed
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
– -$2.65K -3 Closed
1 2 3
4